Healthcare Sector
298 healthcare stocks ranked by market capitalization. Updated October 7, 2026.
The Healthcare sector includes 298 US-listed stocks tracked by MetaCap with a combined market capitalization of $8.90T. As of October 7, 2026, the sector is up 0.74% on the day, based on the XLV sector ETF, outperforming the S&P 500 (-0.26%). The largest companies are Eli Lilly (LLY) at $1.1T, Johnson & Johnson (JNJ) at $623.2B and AbbVie (ABBV) at $479.1B, together 24.3% of the sector's value. Among the companies on this page, 30 of 50 are higher today; Moderna (MRNA) is the best performer (+4.71%) and IDEXX Laboratories (IDXX) the weakest (-1.69%).
Summary generated from market data by MetaCap's automated system. Methodology
About the Healthcare sector
Healthcare includes pharmaceutical and biotechnology companies, medical device makers, health insurers, hospitals and life-science tools providers. Results depend on drug pipelines and patents, regulatory approvals, and government reimbursement policy.
Largest healthcare stocks by market cap
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1,185.83 | +2.45% | 1.61M | $1.06T |
| 2 | JNJ | Johnson & Johnson | 258.60 | +1.50% | 3.03M | $623.20B |
| 3 | ABBV | AbbVie Inc. | 271.12 | +1.66% | 3.04M | $479.10B |
| 4 | MRK | Merck & Company Inc. | 142.55 | +0.43% | 3.66M | $351.68B |
| 5 | UNH | UnitedHealth Group Incorporated | 374.79 | -0.41% | 3.47M | $336.41B |
| 6 | NVS | Novartis AG | 143.10 | +1.64% | 1.49M | $271.99B |
| 7 | AZN | AstraZeneca PLC | 160.06 | +0.91% | 1.33M | $248.24B |
| 8 | TMO | Thermo Fisher Scientific Inc | 659.82 | +0.49% | 1.16M | $243.97B |
| 9 | AMGN | Amgen Inc. | 411.48 | +2.21% | 1.37M | $222.46B |
| 10 | GILD | Gilead Sciences Inc. | 146.53 | +1.59% | 2.41M | $181.69B |
| 11 | ABT | Abbott Laboratories | 98.64 | +0.48% | 4.79M | $170.68B |
| 12 | NVO | Novo Nordisk A/S | 38.20 | +1.79% | 10.38M | $168.63B |
| 13 | PFE | Pfizer Inc. | 28.02 | +1.87% | 17.30M | $159.68B |
| 14 | DHR | Danaher Corporation | 218.22 | +1.21% | 2.59M | $153.41B |
| 15 | ISRG | Intuitive Surgical Inc. | 411.87 | +1.76% | 1.23M | $145.50B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 504.99 | +0.53% | 361.83K | $128.00B |
| 17 | BMY | Bristol-Myers Squibb Company | 59.74 | +0.25% | 7.27M | $122.03B |
| 18 | CVS | CVS Health Corporation | 88.34 | +2.21% | 5.39M | $112.98B |
| 19 | MDT | Medtronic plc. | 85.69 | -1.61% | 40.63M | $109.60B |
| 20 | MCK | McKesson Corporation | 911.25 | -1.13% | 609.55K | $106.24B |
| 21 | SYK | Stryker Corporation | 275.88 | -0.83% | 1.26M | $105.82B |
| 22 | SNY | Sanofi ADS | 40.06 | +1.26% | 1.47M | $95.99B |
| 23 | HCA | HCA Healthcare Inc. | 437.85 | +1.31% | 587.51K | $94.79B |
| 24 | GSK | GSK plc ADR | 47.06 | +0.98% | 4.99M | $94.28B |
| 25 | ELV | Elevance Health Inc. | 404.19 | +1.02% | 531.40K | $87.66B |
| 26 | MRNA | Moderna Inc. | 196.29 | +4.71% | 11.48M | $78.37B |
| 27 | REGN | Regeneron Pharmaceuticals Inc. | 742.04 | +0.45% | 385.20K | $76.40B |
| 28 | CI | The Cigna Group | 279.01 | +1.69% | 809.61K | $73.73B |
| 29 | COR | Cencora Inc. | 317.18 | +0.26% | 469.82K | $60.53B |
| 30 | BSX | Boston Scientific Corporation | 41.57 | -1.47% | 11.60M | $60.24B |
| 31 | TAK | Takeda Pharmaceutical Company Limited ADR | 18.33 | +1.27% | 1.97M | $58.56B |
| 32 | ARGX | argenx SE ADR | 924.45 | -0.65% | 190.53K | $57.49B |
| 33 | NTRA | Natera Inc. | 396.21 | -1.11% | 2.29M | $57.11B |
| 34 | CAH | Cardinal Health Inc. | 231.30 | -0.92% | 520.80K | $53.56B |
| 35 | EW | Edwards Lifesciences Corporation | 85.72 | -0.88% | 1.83M | $49.41B |
| 36 | BDX | Becton Dickinson and Company | 180.05 | -0.14% | 1.11M | $49.04B |
| 37 | HUM | Humana Inc. | 398.27 | -1.48% | 1.39M | $47.82B |
| 38 | MDLN | Medline Inc. Class A | 35.53 | -0.07% | 2.92M | $47.80B |
| 39 | A | Agilent Technologies Inc. | 168.73 | -0.35% | 1.67M | $47.58B |
| 40 | VEEV | Veeva Systems Inc. Class A | 284.21 | +0.25% | 597.72K | $46.02B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 39.00 | -0.34% | 1.96M | $45.48B |
| 42 | RVMD | Revolution Medicines Inc. | 199.65 | -0.11% | 812.06K | $42.79B |
| 43 | WAT | Waters Corporation | 434.64 | -0.41% | 506.12K | $42.68B |
| 44 | IQV | IQVIA Holdings Inc. | 257.85 | -0.82% | 799.76K | $42.44B |
| 45 | ONC | BeOne Medicines Ltd. ADR | 363.01 | +0.06% | 98.90K | $41.30B |
| 46 | ILMN | Illumina Inc. | 269.43 | -1.50% | 1.84M | $40.68B |
| 47 | IDXX | IDEXX Laboratories Inc. | 506.68 | -1.69% | 487.09K | $39.92B |
| 48 | HLN | Haleon plc ADR | 9.04 | +1.86% | 14.19M | $39.73B |
| 49 | BIIB | Biogen Inc. | 222.23 | -0.30% | 860.23K | $32.84B |
| 50 | RPRX | Royalty Pharma plc Class A | 56.56 | +0.21% | 1.74M | $32.68B |
Frequently asked questions
- How many healthcare stocks are there?
- MetaCap tracks 298 US-listed stocks in the Healthcare sector, worth a combined $8.90T.
- What is the largest healthcare company?
- Eli Lilly (LLY) is the largest healthcare stock by market capitalization, at about $1.06T.
- What ETF tracks the healthcare sector?
- XLV is the Select Sector SPDR fund for Healthcare, and MetaCap uses it as the benchmark for the sector's daily performance. Other providers, such as Vanguard and iShares, offer similar sector funds.
- How is the healthcare sector doing today?
- As of October 7, 2026, the Healthcare sector is up 0.74% based on XLV.
Prices as of Oct 7, 3:34 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer